Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Clin Cancer Res. 2018 Sep 19;25(1):325–333. doi: 10.1158/1078-0432.CCR-18-1317

Figure 3.

Figure 3.

Disease reduction following surgical resection of primary NB. Mice underwent implantation of 1×106 CHLA-255-Fluc NB cells followed by surgical removal of the primary tumor one week later. (A) Bioluminescent images taken 7 days post NB cell injection and just prior to tumor removal. Post-resection images of mice were taken one day after resection and compared to pre-resection baseline. (B) Surgical resection of the primary tumor resulted in a 95% reduction in disease burden.